丸激素治疗对绝经后妇女心血管风险的影响
Rhys C Britton1, Nicole F Beamish1
1School of Kinesiology and Health Studies, Queen's University, Kingston, Ontario K7L 3N6, Canada.
绝经后妇女的丸激素治疗显示出对心血管风险因素的潜在益处,但需要更多的研究来了解其影响和机制. 进一步的研究对于基于证据的临床应用至关重要.
科学领域:
- 内分泌学 在内分泌学.
- 心血管健康 心血管健康
- 妇女健康 妇女健康
背景情况:
- 更年期与影响女性健康的荷尔蒙变化有关.
- 心血管疾病是绝经后妇女死亡的主要原因.
- 在女性生理学中的作用及其潜在的治疗应用正在调查中.
研究的目的:
- 审查目前关于丸激素治疗对绝经后妇女心血管风险因素的影响的证据.
- 识别现有研究中的知识差距.
主要方法:
- 进行了对同行评审文献的范围审查.
- 在MEDLINE,Embase和谷歌学者中进行了搜索.
- 从7篇选定的文章中提取和综合数据.
主要成果:
- 低剂量丸激素治疗,通常与雌激素一起,可能会积极影响身体组成,功能能力,胰岛素敏感性,炎症标志物和胆固醇水平.
- 关于对心血管风险因素的直接影响的证据仍然有限.
- 在这种人群中,丸激素治疗的作用机制尚未完全理解.
结论:
- 丸激素治疗显示出改善绝经后妇女某些健康参数的前景.
- 在了解丸激素治疗对心血管风险的具体影响方面存在重大差距.
- 高质量的临床试验是建立基于证据的指南所必需的.
更多相关视频
14:26A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
Published on: April 7, 2014
07:40Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
Published on: October 10, 2019
相关概念视频
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Menopause
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Exercise Stress Test
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
